mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
0.022 |
0.7 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
UNC0638 |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |